Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview.
about
Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signalingNitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgeryIdentification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS geneLow NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy cNitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgeryEpigenetic associations in relation to cardiovascular prevention and therapeuticsThe dual role of iNOS in cancerPoly-s-nitrosated albumin as a safe and effective multifunctional antitumor agent: characterization, biochemistry and possible future therapeutic applicationsStructure-Based Design and Synthesis of N ω -Nitro- l -Arginine-Containing Peptidomimetics as Selective Inhibitors of Neuronal Nitric Oxide Synthase. Displacement of the Heme Structural WaterCardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused ratsEndotoxin-induced acute lung injury is enhanced in rats with spontaneous hypertensionTemporal changes in vascular reactivity in early diabetes mellitus in rats: role of changes in endothelial factors and in phosphodiesterase activity.Photoinduced release of nitroxyl and nitric oxide from diazeniumdiolatesPoly(vinyl alcohol) films for topical delivery of S-nitrosoglutathione: effect of freezing-thawing on the diffusion properties.Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in hypertensionPharmacotherapy for end-stage coronary artery disease.Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivoHeadache-type adverse effects of NO donors: vasodilation and beyondHyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent.Nitrates and nitrites in the treatment of ischemic cardiac diseaseChronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic micecGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.Photoactive Ruthenium Nitrosyls: Effects of Light and Potential Application as NO Donors.Nitric oxide and cisplatin resistance: NO easy answers.Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice.Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury.The potential of nitric oxide therapeutics in stroke.Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart FailureTopical combinations to treat microvascular dysfunction of chronic postischemia painChronic NOS inhibition accelerates NAFLD progression in an obese rat model.Cardiac NO signalling in the metabolic syndrome.Nitric oxide and other novel therapies for pulmonary hypertension.Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions.Natural product nitric oxide chemistry: new activity of old medicines.Nitric oxide release: part II. Therapeutic applications.Recent developments in nitric oxide donor drugs.Selective β2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury.Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.Out-patient management of chronic heart failure.Sublingual Nitroglycerin Administration in Coronary Computed Tomography Angiography: a Systematic Review.
P2860
Q23922830-8FE9F813-3778-4C61-9943-08D4CE09265CQ24200669-CDF80267-FD93-4838-8F4F-DC4040B12F5EQ24540361-42B1FB2F-86BE-43FF-B67F-6225DE381E45Q24796647-F975F9C1-0618-4FA0-A13C-0CD11A91BCEEQ26470504-103B78AD-0642-4991-9CDD-6E1550A91C57Q26771428-CC7A655A-2998-48B7-9537-B024C1041BDFQ26786135-DED914C2-64B6-44C3-BF00-A41A5DC82E12Q26859056-6537CBE4-C616-429F-BFCE-1E1597487BB9Q27644394-7FCD5C08-C39E-46B6-AB3A-EED71C069458Q28211479-7C0EB259-0016-4127-9070-DB75592513C5Q28565578-BD1357DC-A6A5-4E63-9AA6-A276ABDCBC09Q29347153-FD5509DE-E721-415F-9292-63D233B51F03Q33284032-9AEDE44F-D99E-46E5-AC7B-ACA8B20C2EB5Q33526573-FC32BFF2-8F9A-4B88-9866-37A9875E4D2EQ33577228-927F1B0C-A304-4F26-8751-C61C452350D6Q33610142-CADBA1D7-8A59-4D4D-8FD3-EF252728EBACQ33784459-3662A8B8-5DA3-41DA-BDB4-A3D00D27E2E4Q33812736-FC8498D6-490F-467C-AF36-C53DA4AE4EE0Q33873092-EB050A33-151F-4622-9CF2-C2B459693ACCQ33910541-EF8E25F5-CBB9-483F-85E1-055C56CFB62AQ34156437-F48AD9DD-C8A9-4C71-BE05-56E027158E74Q34244951-35B0C3B7-4506-41C4-9D3C-7A09E0A8B35BQ34259551-4D108833-05F9-43C1-9E0B-BC9F385BC706Q34574620-09FA9CD3-6733-440B-BE6E-3810C6D11371Q34961540-0D515999-8438-48CB-92C8-DEAC328B708AQ35062604-2CF078C1-6941-49C3-9A27-2D68460FD8C7Q35073369-A127ECE0-A231-417B-A11D-1CF95A7253A0Q35121079-D2F9190D-5967-47A3-B2B0-7D8EBAC6A9DBQ35126155-AFB3A38E-49D4-4E3F-96B4-3D9E61DA0460Q35178651-FDFC6F64-9815-471A-A65C-948981D2E4ABQ35204828-A9FB621A-6A5C-443E-8855-99075F77E062Q35750204-20109817-8246-45AA-821C-B7CA04C53A9EQ35781399-367401C1-E84E-445A-9839-311C23CDB028Q35882629-7ABE4744-FDCD-4133-9ADE-2FAD6B385C1AQ35926097-AD21E633-A7DA-4A94-A866-A5960E5D8B7BQ36052815-F1634C88-73BE-4201-A36E-1528F23CA4AFQ36106686-B8FB9DAE-1C41-486E-972E-D691D14E1C80Q36196462-7016AC36-6CCF-40B4-9489-AA88CD464878Q36249926-87B16E21-0FD1-46BA-92DF-83492AD86104Q36258292-A8C0C568-73A7-4A59-ACB3-CE3CB7B0557C
P2860
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nitric oxide donors and cardio ...... of nitric oxide: an overview.
@ast
Nitric oxide donors and cardio ...... of nitric oxide: an overview.
@en
Nitric oxide donors and cardio ...... of nitric oxide: an overview.
@nl
type
label
Nitric oxide donors and cardio ...... of nitric oxide: an overview.
@ast
Nitric oxide donors and cardio ...... of nitric oxide: an overview.
@en
Nitric oxide donors and cardio ...... of nitric oxide: an overview.
@nl
prefLabel
Nitric oxide donors and cardio ...... of nitric oxide: an overview.
@ast
Nitric oxide donors and cardio ...... of nitric oxide: an overview.
@en
Nitric oxide donors and cardio ...... of nitric oxide: an overview.
@nl
P50
P356
P1433
P1476
Nitric oxide donors and cardio ...... of nitric oxide: an overview.
@en
P356
10.1161/HH0102.102330
P577
2002-01-01T00:00:00Z